Diffusion Pharmaceuticals

+$0.37 (+4.97%) Today
-$0.06 (-0.77%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DFFN and other ETFs, options, and stocks.

About DFFN

Diffusion Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapies that enhance the body's ability to deliver oxygen. The firm's product candidate, Trans Sodium Crocetinate, is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia.

CEO
Robert J. Cobuzzi
Employees
16
Headquarters
Charlottesville, Virginia
Founded
2001

DFFN Key Statistics

Market cap
15.92M
Price-Earnings ratio
—
Dividend yield
—
Average volume
69.39K
High today
$7.85
Low today
$7.41
Open price
$7.41
Volume
46.20K
52 Week high
$9.35
52 Week low
$0.166

DFFN Earnings

-$2.22
-$1.48
-$0.74
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$2.22 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure